IL78476A0 - Highly repetitive antigens of plasmodium falciparum - Google Patents

Highly repetitive antigens of plasmodium falciparum

Info

Publication number
IL78476A0
IL78476A0 IL78476A IL7847686A IL78476A0 IL 78476 A0 IL78476 A0 IL 78476A0 IL 78476 A IL78476 A IL 78476A IL 7847686 A IL7847686 A IL 7847686A IL 78476 A0 IL78476 A0 IL 78476A0
Authority
IL
Israel
Prior art keywords
plasmodium falciparum
highly repetitive
antigens
repetitive antigens
highly
Prior art date
Application number
IL78476A
Other languages
English (en)
Original Assignee
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall filed Critical Inst Medical W & E Hall
Publication of IL78476A0 publication Critical patent/IL78476A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
IL78476A 1985-04-11 1986-04-11 Highly repetitive antigens of plasmodium falciparum IL78476A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH010885 1985-04-11
AUPH164085 1985-07-25

Publications (1)

Publication Number Publication Date
IL78476A0 true IL78476A0 (en) 1986-08-31

Family

ID=25642930

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78476A IL78476A0 (en) 1985-04-11 1986-04-11 Highly repetitive antigens of plasmodium falciparum

Country Status (4)

Country Link
EP (1) EP0217877A4 (de)
IL (1) IL78476A0 (de)
WO (1) WO1986006075A1 (de)
ZW (1) ZW8386A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81026A0 (en) * 1985-12-24 1987-03-31 Inst Medical W & E Hall Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
FR2672290B1 (fr) * 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
EP2785370B1 (de) * 2011-12-02 2021-07-21 Rhode Island Hospital Impfstoff gegen falciparum-malaria

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
WO1983002896A1 (en) * 1982-02-17 1983-09-01 D'antonio, Lawrence, E. Method for the purification of parasite antigenic factors
DE3221881A1 (de) * 1982-06-09 1983-12-15 Münchener Apparatebau Kimmel GmbH, 8012 Ottobrunn Verfahren zur herstellung eines impfstoffs gegen parasitaere krankheitserreger
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
GB2154592A (en) * 1984-02-22 1985-09-11 Wellcome Found Cloning of a malarial gene
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Also Published As

Publication number Publication date
EP0217877A1 (de) 1987-04-15
ZW8386A1 (en) 1986-07-23
EP0217877A4 (de) 1988-03-30
WO1986006075A1 (en) 1986-10-23

Similar Documents

Publication Publication Date Title
AU5293486A (en) Malaria vaccine against plasmodium falciparum
NZ215034A (en) Production of plasmodium falciparum cs protein
PH22185A (en) Treatment of malaria
GB2176191B (en) Antigens of plasmodium falciparum
IL79900A0 (en) Combination preparations for the treatment of malaria
ZA869671B (en) Asexual blood stage antigens of plasmodium falciparum
IL80305A0 (en) Preparation of epsilon-butyrolactams
ZW8386A1 (en) Highly repetitive antigens of plasmodium falciparum
GB8529729D0 (en) Preparation of fish-noodles
AU5603786A (en) Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
GB8504268D0 (en) Preparation of fluorinated pyridines
ZA862732B (en) Highly repetitive antigens of plasmodium falciparum
IL78379A (en) Preparation of 2-mercaptobenzoxazoles
IL80657A0 (en) Preparation of monochloropinacolone
AU6687786A (en) Asexual blood stage antigens of plasmodium falciparum
GB8916546D0 (en) Rhoptry antigen of plasmodium falciparum
GB2200642B (en) Small molecular weight antigen of plasmodium falciparum
ZA856960B (en) Antigens of plasmodium falciparum
AU7699887A (en) Merozoite surface antigen of plasmodium falciparum
IL78977A (en) Preparation of alkyloxiranes
GB2200641B (en) Merozoite surface antigen of plasmodium falciparum
AU3069989A (en) Rhoptry membrane antigen of plasmodium falciparum
ZA875266B (en) Merozoite surface antigen of plasmodium falciparum
NZ221114A (en) Merozoite surface antigen of plasmodium falciparum
DE3566532D1 (en) Preparation of 4-fluorophenols